Meeting
2017 ASCO Annual Meeting
A 17-gene panel for prediction of adverse surgical pathology in the setting of MRI-guided prostate biopsy.
Authors
Amirali Salmasi
University of California, Los Angeles, Los Angeles, CA
Amirali Salmasi , Jonathan W. Said , Steven Raman , Alan W Shindel , Debbie McCullough , Helen Bailey , Megan Rothney , Leonard S. Marks , Phillip G. Febbo , Robert Evan Reiter
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 35, 2017 (suppl; abstr 5063)
DOI
10.1200/JCO.2017.35.15_suppl.5063
Abstract #
5063
Poster Bd #
137
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Comparative transcriptomic analysis of DNA-damage response and androgen receptor pathway activity between biopsy and radical prostatectomy specimens before and after pre-operative real-time MRI-guided stereotactic body radiotherapy.
First Author: Himanshu Nagar
Poster
2019 Genitourinary Cancers Symposium
Validation of MSKCC pre-prostatectomy nomogram in men who undergo MRI-targeted prostate biopsy prior to radical prostatectomy.
First Author: Zachary A Glaser
Poster
2019 Genitourinary Cancers Symposium
A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.
First Author: Zachary Kornberg
Poster
2019 Genitourinary Cancers Symposium
Concordance of systematic and fusion biopsy with surgical pathology.
First Author: Alice Yu